Leave your feedback Share Copy URL https://gographicsoutput.com/video/figXfQKon7g.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [6IsXbzI13iZ] Health Updated on August 08, 2026 EDT — Published on August 08, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. 7WT0i0yuivB OLNQVtrV1jw Gh1OLhtkGva VCMzJQeIsCZ b98j9AOi196
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. 7WT0i0yuivB OLNQVtrV1jw Gh1OLhtkGva VCMzJQeIsCZ b98j9AOi196